Iovance Biotherapeutics Inc (DE:2LB)
FRANKFURT:2LB
Iovance Biotherapeutics (2LB) Ownership Overview
0.35% Insiders
11.32%
Mutual Funds
18.14% Other Institutional Investors
14.13% ETFs
56.07% Public Companies and
Individual Investors
The ownership structure of Iovance Biotherapeutics (DE:2LB) stock is a mix of institutional, retail, and individual investors. Approximately 43.58% of the company’s stock is owned by Institutional Investors, 0.35% is owned by Insiders, and 56.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 06, 2025 | xxxxxxxxxxxxx | $55200 | |
May 27, 2025 | xxxxxxxxxxxxx | $9688 | |
May 16, 2025 | xxxxxxxxxxxxx | $42250 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $416909 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,228,889 | Institution | 5.88% | 86,521,363 | |
| 21,528,240 | Institution | 5.23% | 76,877,345 | |
| 15,444,096 | Institution | 3.75% | 55,150,867 | |
| 10,465,160 | Institution | 2.54% | 37,371,086 | |
| 5,014,348 | Institution | 1.22% | 17,906,237 | |
| 3,383,236 | Institution | 0.82% | 12,081,536 | |
| 3,049,734 | Institution | 0.74% | 10,890,600 | |
| 2,940,670 | Institution | 0.71% | 10,501,133 | |
| 2,008,681 | Institution | 0.49% | 7,173,000 | |
| 1,833,421 | Institution | 0.45% | 6,547,146 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,528,240 | Institution | 5.23% | 76,877,345 | |
| 5,014,348 | Institution | 1.22% | 17,906,237 | |
| 3,383,236 | Institution | 0.82% | 12,081,536 | |
| 3,049,734 | Institution | 0.74% | 10,890,600 | |
| 2,940,670 | Institution | 0.71% | 10,501,133 | |
| 1,516,866 | Institution | 0.37% | 5,416,728 | |
| 1,468,244 | Institution | 0.36% | 5,243,099 | |
| 1,194,140 | Institution | 0.29% | 4,264,274 | |
| 945,683 | Institution | 0.23% | 3,377,034 | |
| 932,163 | Institution | 0.23% | 3,328,754 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Iovance Biotherapeutics Inc (DE:2LB)?
According to the latest TipRanks data, approximately 18.14% of the company's stock is held by institutional investors, 0.35% is held by insiders, and 56.07% is held by retail investors.
What percentage of Iovance Biotherapeutics Inc (DE:2LB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.14% of Iovance Biotherapeutics Inc (DE:2LB) stock is held by institutional investors.
What percentage of Iovance Biotherapeutics Inc (DE:2LB) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.07% of Iovance Biotherapeutics Inc (DE:2LB) stock is held by retail investors.
Who owns the most shares of Iovance Biotherapeutics Inc (DE:2LB)?
Vanguard owns the most shares of Iovance Biotherapeutics Inc (DE:2LB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.